124I-ACD-101

N/A

Report date: 2025/11/14 09:32:52

NME

Base Information

Drug Name124I-ACD-101

Drug Alias Name124I-ACD-101[124I]ACD-101[124I]TX-101124I-TX-101[124I]IPA +[6]

ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Iodine > 124I +[4]

Mechanisms of ActionL-type amino acid transporter 1 inhibitors

TargetsL-type amino acid transporter 1

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesTherapeia GmbH & Co KG

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesTelix Pharmaceuticals Ltd

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A